BioTrinity 2013

Published: 13-Feb-2013

14 - 16 May 2013

Conference

Newbury, Berkshire


BioTrinity 2013 will be a gathering of the UK’s bioindustry, bringing together a critical mass of active investors from global pharma and innovative biotech and medtech companies.

This year will showcase a hand-selected group of R&D companies, watched by senior executives from more than 100 investment firms, and build on previous years’ participation by top global pharma; Novartis, AstraZeneca, Shire, Merck, GSK, Pfizer, Boehringer, Takeda, Teva, Lilly, Abbott, Merck Serono and Novo A/S.

Organiser: OBN

www.biotrinity.com/silverstripe/

Trending Articles

  1. Cleanroom Conference UK 22–23 May 2024 | Exhibition | Birmingham, UK
  2. Making Pharmaceuticals 23–24 April 2024 | Exhibition | Coventry, UK
  3. Lounges 23-25 April 2024 | Conference | Messe Karlsruhe, Germany
  4. Interphex 16-18 April 2024 | Conference and Exhibition | New York, US
  5. KOREA CHEM 2023 18-21 April 2023 | Exhibition | Korea

You may also like

Research & Development

BioForward - The 'Roadmap for Growth' Life Sciences Event

4 October 2018 | Conference | Birmingham, UK
Research & Development

ABPI and OBN sign Memorandum of Understanding

To look for partnership initiatives to help build better public profile and understanding of all biosciences
Research & Development

BioTrinity

12 - 14 May 2014, Conference, Novotel London West, UK
Pharmaceutical

BioTrinity 2013

<b>14 - 16 May 2013</b><br> <i>Conference</i><br> Newbury, Berkshire
Subscribe now